Analgesics - US - June 2004

Contents

INTRODUCTION AND ABBREVIATIONS

• Introduction
• Other Relevant Reports
• Definition
• Abbreviations Terms
• Abbreviations
• Terms

EXECUTIVE SUMMARY

• Baby boomers and seniors are major drivers for analgesics market
• Babies and toddler formulations grow sales
• Specific symptom pain relief could generate new customers
• OTC vs. prescription drugs
• Prevention may be the best medicine
• Targeting a specific type of pain
• Big gains in external analgesics market
• Interest in alternative products
• A $2.2 billion market
• Delivery systems distinguish segments
• Four big players and store brands account for most sales
• McNeil is biggest spender on media
• Drug stores edge out supermarkets for sales in 2003
• Respondents are more likely to use extra strength products
• Two thirds of respondents take pain killers for headaches
• Drug stores and supermarkets favorite purchase sites
• Future trends
• Analgesics forecast to decline

MARKET DRIVERS

• Aging population boosts market
• Figure 1: U.S. population projections, 1998, 2003 and 2008
• More products for children
• Incidence of specific ailments
• Figure 2: Prevalence of specific conditions/ailments among population aged 18 and older, by percent of population, 2001
• OTC and prescription drug use
• Figure 3: Usage of OTC vs. prescription drugs for specific ailments, January-September 2003
• Prophylactic uses of analgesics
• Analgesics targeting specific pain symptoms
• Competition from other products
• External analgesics
• Alternative medicines

MARKET SIZE TRENDS

• Figure 4: Total U.S. retail sales of analgesic products, at current and constant prices, 1998-2003*
• Graph 1: Total U.S. retail sales of internal analgesic products, at current and constant prices, 1998-2003*

MARKET SEGMENTATION

• Figure 5: Sales of analgesics, segmented by delivery system, 2001 and 2003*
• Analgesic tablets
• Figure 6: Sales of analgesic tablets, at current and constant prices, 1998-2003*
• Analgesic liquids
• Figure 7: Sales of analgesic liquids, at current and constant prices, 1998-2003*

SUPPLY STRUCTURE

COMPANIES AND BRANDS

• Figure 8: Manufacturer sales of internal analgesic products in the U.S., 2001 2003*
• Analgesic tablets
• Figure 9: Manufacturer brand sales of internal analgesic tablets in the U.S., 2001 and 2003*
• Analgesic liquids
• Figure 10: Manufacturer brand sales of internal analgesic liquids in the U.S., 2001 2003*
• Profiles of Major Manufacturers
• McNeil Consumer Products (Johnson Johnson)
• Wyeth
• Bayer Consumer Health Division International
• Bristol Myers-Squibb

ADVERTISING PROMOTION

• McNeil Consumer Products
• Bayer Consumer Health Division International
• Bristol Myers-Squibb
• Wyeth

RETAIL DISTRIBUTION

• Introduction
• Figure 11: U.S. retail sales of internal analgesic products, by channel, 2001 and 2003*
• Drug stores
• Figure 12: U.S. drug store sales of internal analgesics, at current and constant prices, 1998-2003
• Drug store operating data
• Figure 13: Top drug store operating statistics, latest fiscal year-end
• Figure 14: Percentage change from latest fiscal year-end versus year prior
• Supermarkets
• Figure 15: U.S. supermarket sales of internal analgesics, at current and constant prices, 1998-2003
• Supermarket operating data
• Figure 16: Top supermarket operating statistics, latest fiscal year-end
• Figure 17: Percentage change from latest fiscal year-end versus year prior

THE CONSUMER

• Introduction
• Usage of analgesics
• Figure 18: Usage of OTC analgesics, January 2003-September 2003
• Figure 19: Usage of OTC analgesics, by gender, January 2003-September 2003
• Figure 20: Usage of OTC analgesics, by age, January 2003-September 2003
• Figure 21: Usage of OTC analgesics, by race/ethnicity, January 2003-September 2003
• Types of analgesics used
• Figure 22: Types of analgesics used, January 2003-September 2003
• Figure 23: Types of analgesics used, by age, January 2003-September 2003
• Figure 24: Types of analgesics used, by race/ethnicity, January 2003-September 2003
• Forms of analgesics used
• Figure 25: Forms of analgesics used, January 2003-September 2003
• Figure 26: Forms of analgesics used, by age, January 2003-September 2003
• Figure 27: Forms of analgesics used, by race/ethnicity, January 2003-September 2003
• Reasons for using OTC analgesics
• Figure 28: Ailments for which OTC analgesics are used, January 2003-September 2003
• Figure 29: Ailments for which OTC analgesics are used, by gender, January 2003-September 2003
• Figure 30: Ailments for which OTC analgesics are used, by age, January 2003-September 2003
• Figure 31: Ailments for which OTC analgesics are used, by race/ethnicity, January 2003-September 2003
• Purchase venues for OTC analgesics
• Figure 32: Purchase venues for OTC pain relievers, May 2004
• Figure 33: Purchase venues for OTC pain relievers, by age, May 2004
• Figure 34: Purchase venues for OTC pain relievers, by household income, November 2000
• Figure 35: Purchase venues for OTC pain relievers, by race/ethnicity, November 2000
• Interest in new forms of analgesics
• Figure 36: Interest in new forms of pain relievers, May 2004
• Figure 37: Interest in new forms of pain relievers, by age, May 2004
• Figure 38: Interest in new forms of pain relievers, by household income, May 2004
• Attitudes and opinions concerning analgesics
• Figure 39: Attitudes towards analgesics, May 2004
• Figure 40: Attitudes towards analgesics, by age, May 2004
• Analgesics and health issues
• Figure 41: Knowledge of potential risk of mixing acetominophen and alcohol, May 2004
• Figure 42: Knowledge of potential risk of mixing acetominophen and alcohol, by age, May 2004
• Opinions concerning OTC and prescription medications
• Figure 43: Attitudes towards OTC vs. prescription medications, January 2003-September 2003
• Figure 44: Attitudes towards OTC vs. prescription medications, by age, January 2003-September 2003
• Figure 45: Attitudes towards OTC vs. prescription medications, by race/ethnicity, January 2003-September 2003
• Summary

FUTURE FORECAST

FUTURE TRENDS

• Aging population will help drive sales
• Interest in children's products will also continue
• Specific ailments require specific treatments
• Prophylactic usage of analgesics may drive market
• Competition

MARKET FORECAST

• Analgesics
• Figure 46: Forecast of total U.S. retail sales of analgesic products, at current and constant prices, 2003-2008
Graph 2: Sales of analgesics at current prices, 1998-2008
• Analgesic Tablets
• Figure 47: Forecast of U.S. sales of analgesic tablets, at current and constant prices, 2003-2008
• Analgesic Liquids
• Figure 48: Forecast of U.S. sales of analgesic liquids, at current and constant prices, 2003-2008
• Forecast Factors

APPENDIX: TRADE ASSOCIATIONS

APPENDIX: NEW PRODUCT BRIEFS

• Chattem: Pamprin All Day Maximum Strength Pain Reliever
• McNeil Consumer Products: Tylenol Extra Strength Cool Caplets
• McNeil Consumer Products: Tylenol Arthritis Pain Extended Pain Relief
• Bayer: Bayer Children's Genuine Aspirin Chewable Tablets
• Bayer: Bayer Safety Coated Aspirin
• Bayer: Bayer Mint Flavor Chewable Aspirin
• Bayer: Bayer Women's Aspirin
• Bristol Myers-Squibb: Excedrin Tension Headache

APPENDIX: RESEARCH METHODOLOGY

• Consumer Research
• Sampling Weighting
• Presentation Definition
• Further Analysis
• Trade Research
• Informal trade research
• Formal trade research
• Desk Internet Research
• Sources
• Definitions
• Forecasts

APPENDIX: WHAT IS MINTEL?

• Mintel Publications
• Mintel Services
• Product retrieval
• Retail audits
• Tailored research
• Global New Products Database
• Research Support/Consultancy/MIC
• The Mintel Information Centre (MiC)
• PR Research